Literature DB >> 11129721

Molecular typing of Mycobacterium avium isolates by sequencing of the 16S-23S rDNA internal transcribed spacer and comparison with IS1245-based fingerprinting.

Claudia Novi1, Laura Rindi1, Nicoletta Lari1, Carlo Garzelli1.   

Abstract

The nucleotide sequence of the variable 16S-23S rDNA internal transcribed spacer (ITS) was determined in 32 strains of Mycobacterium avium, including 29 clinical isolates, two environmental isolates and the reference strain M. avium ATCC 35712. The results were compared with those obtained by the IS1245-based restriction fragment length polymorphism (RFLP) assay. The strains belonged to three distinct ITS sequevars, Mav-A, Mav-B and Mav-C. Sixteen of 17 isolates of the Mav-B sequevar were from HIV-positive patients; the Mav-A sequevar included six and five isolates from HIV-positive and HIV-negative individuals, respectively, as well as the two environmental isolates and the M. avium reference strain ATCC 35712; only one isolate, from a HIV-infected patient, belonged to the Mav-C sequevar. IS1245-RFLP analysis of M. avium isolates of sequevars Mav-A and Mav-B showed that isolates occurring in clusters of identical or highly related RFLP patterns generally belong to the same sequevar, and that M. avium strains belonging to the same sequevar may present distinct and unrelated IS1245-RFLP patterns. The question of the molecular markers specific for M. avium clones pathogenic for man is discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11129721     DOI: 10.1099/0022-1317-49-12-1091

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  6 in total

1.  Evaluation of genotype and LiPA MYCOBACTERIA assays for identification of Finnish mycobacterial isolates.

Authors:  Johanna Mäkinen; Aleksi Sarkola; Merja Marjamäki; Matti K Viljanen; Hanna Soini
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

Review 2.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

3.  Most human isolates of Mycobacterium avium Mav-A and Mav-B are strong producers of hemolysin, a putative virulence factor.

Authors:  Laura Rindi; Daniela Bonanni; Nicoletta Lari; Carlo Garzelli
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

4.  Genetic diversity of Mycobacterium avium isolates recovered from clinical samples and from the environment: molecular characterization for diagnostic purposes.

Authors:  Julio Alvarez; Ignacio Gómez García; Alicia Aranaz; Javier Bezos; Beatriz Romero; Lucía de Juan; Ana Mateos; Enrique Gómez-Mampaso; Lucas Domínguez
Journal:  J Clin Microbiol       Date:  2008-02-13       Impact factor: 5.948

Review 5.  Mycobacterium avium in the postgenomic era.

Authors:  Christine Y Turenne; Richard Wallace; Marcel A Behr
Journal:  Clin Microbiol Rev       Date:  2007-04       Impact factor: 26.132

6.  Association between 16S-23S internal transcribed spacer sequence groups of Mycobacterium avium complex and pulmonary disease.

Authors:  Jason E Stout; Gregory W Hopkins; Jay R McDonald; Anita Quinn; Carol D Hamilton; L Barth Reller; Richard Frothingham
Journal:  J Clin Microbiol       Date:  2008-06-11       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.